Globus Medical Inc
NYSE:GMED

Watchlist Manager
Globus Medical Inc Logo
Globus Medical Inc
NYSE:GMED
Watchlist
Price: 84.72 USD -0.22% Market Closed
Market Cap: 11.5B USD
Have any thoughts about
Globus Medical Inc?
Write Note

Gross Margin
Globus Medical Inc

58.1%
Current
70%
Average
47.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
58.1%
=
Gross Profit
1.4B
/
Revenue
2.5B

Gross Margin Across Competitors

Country US
Market Cap 11.5B USD
Gross Margin
58%
Country US
Market Cap 204.9B USD
Gross Margin
56%
Country US
Market Cap 195.2B USD
Gross Margin
67%
Country US
Market Cap 146.7B USD
Gross Margin
64%
Country US
Market Cap 132.6B USD
Gross Margin
69%
Country IE
Market Cap 110.6B USD
Gross Margin
66%
Country US
Market Cap 64.7B USD
Gross Margin
45%
Country DE
Market Cap 55.6B EUR
Gross Margin
38%
Country CN
Market Cap 319.2B CNY
Gross Margin
65%
Country US
Market Cap 41.6B USD
Gross Margin
79%
Country US
Market Cap 37.7B USD
Gross Margin
41%
No Stocks Found

Globus Medical Inc
Glance View

Market Cap
11.5B USD
Industry
Health Care

Globus Medical Inc. is a prominent player in the expanding spinal surgery market, leveraging innovation and patient-centric solutions to elevate the standards of care in orthopedic surgery. Founded in 2003, the company has quickly established itself as a leader by developing a comprehensive range of spinal implants and surgical instruments that emphasize minimally invasive techniques. This focus not only enhances patient recovery but also supports surgeons in their pursuit of optimal outcomes. With a robust pipeline of products and a commitment to research and development, Globus Medical aims to maintain its competitive edge by addressing the evolving needs of healthcare professionals and patients alike. For investors, Globus Medical represents a compelling opportunity, as its strong revenue growth and strategic initiatives indicate a promising future. The company has experienced consistent financial performance, underpinned by a growing market demand for spine-related procedures due to aging demographics and an increase in sports-related injuries. Moreover, Globus has pursued strategic acquisitions and collaborations, which have expanded its product offerings and geographical reach. As healthcare systems increasingly prioritize efficiency and patient outcomes, Globus Medical's innovative approach equips it to thrive in an industry ripe with potential, making it an attractive investment choice for those looking to capitalize on the evolving landscape of medical technology.

GMED Intrinsic Value
85.38 USD
Undervaluation 1%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
58.1%
=
Gross Profit
1.4B
/
Revenue
2.5B
What is the Gross Margin of Globus Medical Inc?

Based on Globus Medical Inc's most recent financial statements, the company has Gross Margin of 58.1%.